Apyx Medical Corp
(APYX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,282 | -4,339 | 617 | 109 | -1,535 |
| Depreciation Amortization | 876 | 827 | 857 | 925 | 1,061 |
| Income taxes - deferred | 3,975 | -1,613 | 210 | -76 | -934 |
| Accounts receivable | 90 | 884 | -658 | -126 | 451 |
| Accounts payable and accrued liabilities | 494 | 257 | -284 | 134 | 362 |
| Other Working Capital | 3,687 | 1,171 | -1,526 | 104 | -372 |
| Other Operating Activity | 7,743 | 277 | 949 | 827 | 441 |
| Operating Cash Flow | $-417 | $-2,536 | $165 | $1,897 | $-526 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -630 | -588 | -753 | -542 | 432 |
| Investing Cash Flow | $-630 | $-588 | $-753 | $-542 | $432 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -1,000 |
| Debt Issued | N/A | N/A | N/A | 3,549 | 0 |
| Debt Repayment | -84 | -162 | -130 | -3,851 | -99 |
| Common Stock Issued | 259 | 7,048 | N/A | 0 | 2,776 |
| Common Stock Repurchased | -420 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -899 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,144 | $6,886 | $-130 | $-302 | $1,677 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 89 |
| Beginning Cash Position | 7,924 | 4,162 | 4,880 | 3,827 | 2,155 |
| End Cash Position | 5,733 | 7,924 | 4,162 | 4,880 | 3,827 |
| Net Cash Flow | $-2,191 | $3,762 | $-718 | $1,053 | $1,672 |
| Free Cash Flow | |||||
| Operating Cash Flow | -417 | -2,536 | 165 | 1,897 | -526 |
| Capital Expenditure | -630 | -588 | -753 | -542 | -201 |
| Free Cash Flow | -1,047 | -3,124 | -588 | 1,355 | -727 |